10-74136765-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012095.6(AP3M1):āc.312T>Gā(p.Asp104Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000595 in 1,552,348 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012095.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP3M1 | NM_012095.6 | c.312T>G | p.Asp104Glu | missense_variant | 3/9 | ENST00000355264.9 | NP_036227.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP3M1 | ENST00000355264.9 | c.312T>G | p.Asp104Glu | missense_variant | 3/9 | 1 | NM_012095.6 | ENSP00000347408.4 | ||
AP3M1 | ENST00000372745.1 | c.312T>G | p.Asp104Glu | missense_variant | 4/10 | 1 | ENSP00000361831.1 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000431 AC: 105AN: 243478Hom.: 0 AF XY: 0.000448 AC XY: 59AN XY: 131724
GnomAD4 exome AF: 0.000617 AC: 864AN: 1400122Hom.: 1 Cov.: 30 AF XY: 0.000562 AC XY: 388AN XY: 690774
GnomAD4 genome AF: 0.000388 AC: 59AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.000457 AC XY: 34AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.312T>G (p.D104E) alteration is located in exon 4 (coding exon 2) of the AP3M1 gene. This alteration results from a T to G substitution at nucleotide position 312, causing the aspartic acid (D) at amino acid position 104 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at